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Volume 51, Number 11S Abstracts 17Slation of PSV with angiography (0.833, C. I. 0.8-0.86)
EDVwith angiography (0.755, C. I. 0.71-0.80), and ICA/
CCA systolic ratio with angiography (0.601, C. I. 0.53-
0.66) (p  0.0001). There was no improvement in accu-
racy by adding the EDV values and/or the ratios to the PSV
values. The consensus criteria in diagnosing 50-69% steno-
sis can be significantly improved by using an ICA PSV of
140-230 cm/s with a sens. of 94%, spec. 92%, OA 92%.
Conclusions: Consensus criteria can be used accu-
rately for the diagnosis of 70% stenosis, however the
accuracy can be improved in detecting 50-69% stenosis if
the ICA PSV is changed to 140-230 cm/s.
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SS26.
Thrombus Volume Is Associated With Cardiovascular
Events and Aneurysm Growth in Patients Who Have
Abdominal Aortic Aneurysm
Jonathan Golledge, Adam Parr, Moira McCann, Petra
Buttner, Barbara Bradshaw. James Cook University,
Townsville, QLD, Australia
Objectives: The aims of this study were to prospec-
tively assess the association of infra-renal abdominal aortic
thrombus volume with cardiovascular events and abdomi-
nal aortic aneurysm (AAA) growth.
Methods: 98 patients with AAAs (median diameter 47.2
mm) underwent computed tomography angiography (CTA).
The volumeof thrombus in the infra-renal aortawasmeasured
by a previously validated technique. Patients were followed
prospectively for a median of 3 (inter-quartile range 2.0-3.6)
years and cardiovascular events (nonfatal stroke, nonfatal
myocardial infarction, coronary revascularization, amputation
and cardiovascular death) recorded. 39 patients underwent
repeat CTA a median of 1.5 (inter-quartile range 1.1-3.3)
years later. Kaplan-Meier and Cox-proportional analysis were
used to examine the association of aortic thrombus with
cardiovascular events and average weighted AAA growth.
Results: A total of 28 cardiovascular event occurred
during follow-up. The incidence of cardiovascular events
was 23.4 and 49.2% for patients with small (median) and
large (median) volumes of aortic thrombus, respectively,
at 4 years (p 0.05). AAA thrombus volumemedian was
associated with increased cardiovascular events (RR 2.8,
95% CI 1.01- 5.24) independent of other risk factors
including initial aortic diameter. In the sub-set of patients
with CTA follow-up median annual increase in AAA vol-
ume was 5.1cm3 (inter-quartile range 0.8-10.3). Annual
abdominal aortic volume change was positively correlated
with maximal axial abdominal aortic diameter (r  0.44,
p  0.006) and thrombus volume (r  0.50, p  0.001).Thrombus volume median was associated with rapid
volumetric growth (5 cm3/year), independent of initial
aortic diameter (OR 15.0, 95% CI 1.9-115.7, p  0.009).
Conclusions: AAA thrombus volume was indepen-
dently associated with cardiovascular events and AAA pro-
gression. The mechanisms underlying these associations war-
rant further study in order to determine if anti-thrombotic
therapies reduce outcome events.
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SS27.
Is Endovascular Aortic Repair (EVAR) an Effective
Initial Therapy for All Infected Aortic Aneurysms?
Boonprasit Kritpracha, Dhanakom Premprabha, Jitpreedee
Sungsiri, Wittawat Tantarattanapong, Sorracha Rookka-
pan. Prince of Songkla University, Hat Yai, Thailand
Objectives: To determine the outcome of EVAR for
infected aortic aneurysm in patients with or without aor-
toaerodigestive/aortocaval fistulas.
Methods: From September 2005 to November 2009,
20 patients with infected aortic aneurysm, 17 abdominal
and 3 thoracic, were treated with EVAR at Songklanagarind
hospital, Thailand. There were seven patients presented with
fistula complications, 4 aorto-enteric, 1 aorto-esophageal, 1
aorto-bronchial, and1 aorto-caval fistulas. EVARwas planned
as either a bridge or definite treatment depending on the
patient response. In-hospital mortality and follow-up out-
comes were examined.
Results:The average agewas 67 years old (range, 42-84)
and 16 patients were male. Fever was found in 13 patients
(average, 18 days; range, 2-60) and diarrhea in 3 patients (5, 7
and 21 days) prior to surgery. Hemoculture was positive in 9
patients (45%): 6 salmonella spp., 2 Burkholderia pseudoma-
llei, and 1 Klebsiella pneumoniae. All but one patient with
fever were improved within a few days after EVAR. Overall
in-hospital mortality was 20% (4 out of 20): 43% (3/7) in the
fistula group andonly 8% (1/13) in the nonfistula group.One
conversion to open repair was performed from the fistula
group two weeks after EVAR. During follow-up, 2 of the 4
survivors in the fistula group died at 6 and 18 months from
unrelated causes. There was no death in the nonfistula group
with average follow-up of 19 months (range, 6-47). Inflam-
matory tissue around the aorta and aneurysms were com-
pletely disappeared in 9 of the 12 patients (75%), occurring at
6-month PO in 4 cases, and 1-year PO in 5 cases. The
remaining 3 patients also had significant aneurysm shrunk at
1-year PO. There was no late conversion.
Conclusions: Although starting as a temporary mea-
sure, it seems that EVAR may well be a reasonable mid-
term and possibly long-term treatment for infected aortic
aneurysm without fistulas. However, a poorer outcome was
evidenced in patients with fistula complications.
